Efficacy of Choleretics in Acalculous Gallbladder in Situ After Endoscopic Removal of Biliary Stones

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-03-31

Study Completion Date

2021-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In patients with gallbladder in situ after complete removal of common bile duct (CBD) stones, there is no definite guideline for the management of remnant acalculous gallbladder. This study was planned to evaluate the efficacy of choleretic agents in those patients comparing with non-treatment group during short (2 years) and long-term (5 to 10 years) period. So that, the investigators want to establish the treatment guideline in gallbladder in situ without definite stones following complete removal of CBD stones. Second, the protective or preventive effect of choleretics may be defined.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Treatment Effect for Asymptomatic Common Bile Duct Stone

NCT06215040

Choledocholithiasis Asymptomatic Condition Quality of Life

RECRUITING

Comparison of LCBDE vs ERCP + LC for Choledocholithiasis

NCT02515474

Choledocholithiasis

COMPLETED NA

Effect of Saline Irrigation to DEcrease Rate Of Residual Common Bile Duct Stones

NCT01425177

Common Bile Duct Gallstones

UNKNOWN PHASE3

ETGBD in Surgically Unfit Patients With Both Choledocholithiasis and Cholecystolithiasis

NCT05935969

Efficacy

COMPLETED

Optimal Handling of Common Bile Duct Calculus, a Prospective Study

NCT01708109

Cholelithiasis

TERMINATED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Common Bile Duct Stones Gallbladder in Situ Choleretics Biliary Complications

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Wait-and-see group

After endoscopic clearance of their bile duct stones, this group of patients will be follow up without additional managements

No interventions assigned to this group

Choleretics group

After endoscopic clearance of their bile duct stones, this group of patients receives choleretic agents during 3 months

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Complete clearance of CBD stones
* No definite GB stones
* Agree with the study protocol

Exclusion Criteria

* \< 18 years of age
* Concomitant IHD stones
* Combined malignancy with a limted life span
* Prior cholecystectomy state
* refusal to agree to the study protocol

Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No